Skip to main content
Top
Published in: Quality of Life Research 7/2017

Open Access 01-07-2017 | Review

Utility scores for different health states related to depression: individual participant data analysis

Authors: Spyros Kolovos, Judith E. Bosmans, Johanna M. van Dongen, Birre van Esveld, Dorcas Magai, Annemieke van Straten, Christina van der Feltz-Cornelis, Kirsten M. van Steenbergen-Weijenburg, Klaas M. Huijbregts, Harm van Marwijk, Heleen Riper, Maurits W. van Tulder

Published in: Quality of Life Research | Issue 7/2017

Login to get access

Abstract

Objectives

Depression is associated with considerable impairments in health-related quality-of-life. However, the relationship between different health states related to depression severity and utility scores is unclear. The aim of this study was to evaluate whether utility scores are different for various health states related to depression severity.

Methods

We gathered individual participant data from ten randomized controlled trials evaluating depression treatments. The UK EQ-5D and SF-6D tariffs were used to generate utility scores. We defined five health states that were proposed from American Psychiatric Association and National Institute for Clinical Excellence guidelines: remission, minor depression, mild depression, moderate depression, and severe depression. We performed multilevel linear regression analysis.

Results

We included 1629 participants in the analyses. The average EQ-5D utility scores for the five health states were 0.70 (95% CI 0.67–0.73) for remission, 0.62 (95% CI 0.58–0.65) for minor depression, 0.57 (95% CI 0.54–0.61) for mild depression, 0.52 (95%CI 0.49–0.56) for moderate depression, and 0.39 (95% CI 0.35–0.43) for severe depression. In comparison with the EQ-5D, the utility scores based on the SF-6D were similar for remission (EQ-5D = 0.70 vs. SF-6D = 0.69), but higher for severe depression (EQ-5D = 0.39 vs. SF-6D = 0.55).

Conclusions

We observed statistically significant differences in utility scores between depression health states. Individuals with less severe depressive symptoms had on average statistically significant higher utility scores than individuals suffering from more severe depressive symptomatology. In the present study, EQ-5D had a larger range of values as compared to SF-6D.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hasin, D. S., Goodwin, R. D., Stinson, F. S., et al. (2005). Epidemiology of major depressive disorder: Results from the national epidemiologic survey on alcoholism and related conditions. Archives of General Psychiatry, 62(10), 1097–1106.CrossRefPubMed Hasin, D. S., Goodwin, R. D., Stinson, F. S., et al. (2005). Epidemiology of major depressive disorder: Results from the national epidemiologic survey on alcoholism and related conditions. Archives of General Psychiatry, 62(10), 1097–1106.CrossRefPubMed
2.
go back to reference Waraich, P., Goldner, E. M., Somers, J. M., et al. (2004). Prevalence and incidence studies of mood disorders: A systematic review of the literature. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 49(2), 124–138.CrossRefPubMed Waraich, P., Goldner, E. M., Somers, J. M., et al. (2004). Prevalence and incidence studies of mood disorders: A systematic review of the literature. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 49(2), 124–138.CrossRefPubMed
3.
go back to reference Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine, 3(11), e442. Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine, 3(11), e442.
4.
go back to reference Olesen, J., Gustavsson, A., Svensson, M., et al. (2012). The economic cost of brain disorders in Europe. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies, 19(1), 155–162.CrossRef Olesen, J., Gustavsson, A., Svensson, M., et al. (2012). The economic cost of brain disorders in Europe. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies, 19(1), 155–162.CrossRef
5.
go back to reference Wittchen, H. U., Jacobi, F., Rehm, J., et al. (2011). The size and burden of mental disorders and other disorders of the brain in Europe 2010. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 21(9), 655–679.CrossRef Wittchen, H. U., Jacobi, F., Rehm, J., et al. (2011). The size and burden of mental disorders and other disorders of the brain in Europe 2010. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 21(9), 655–679.CrossRef
6.
go back to reference Saarni, S. I., Suvisaari, J., Sintonen, H., et al. (2007). Impact of psychiatric disorders on health-related quality of life: General population survey. The British Journal of Psychiatry: The Journal of Mental Science, 190, 326–332.CrossRef Saarni, S. I., Suvisaari, J., Sintonen, H., et al. (2007). Impact of psychiatric disorders on health-related quality of life: General population survey. The British Journal of Psychiatry: The Journal of Mental Science, 190, 326–332.CrossRef
7.
go back to reference Saarni, S. I., Viertio, S., Perala, J., et al. (2010). Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. The British Journal of Psychiatry: The Journal of Mental Science, 197(5), 386–394.CrossRef Saarni, S. I., Viertio, S., Perala, J., et al. (2010). Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. The British Journal of Psychiatry: The Journal of Mental Science, 197(5), 386–394.CrossRef
8.
go back to reference Papakostas, G. I., Petersen, T., Mahal, Y., et al. (2004). Quality of life assessments in major depressive disorder: A review of the literature. General Hospital Psychiatry, 26(1), 13–17.CrossRefPubMed Papakostas, G. I., Petersen, T., Mahal, Y., et al. (2004). Quality of life assessments in major depressive disorder: A review of the literature. General Hospital Psychiatry, 26(1), 13–17.CrossRefPubMed
9.
go back to reference Torrance, G. W. (1986). Measurement of health state utilities for economic appraisal. Journal of Health Economics, 5(1), 1–30.CrossRefPubMed Torrance, G. W. (1986). Measurement of health state utilities for economic appraisal. Journal of Health Economics, 5(1), 1–30.CrossRefPubMed
10.
go back to reference Sassi, F. (2006). Calculating QALYs, comparing QALY and DALY calculations. Health Policy and Planning, 21(5), 402–408.CrossRefPubMed Sassi, F. (2006). Calculating QALYs, comparing QALY and DALY calculations. Health Policy and Planning, 21(5), 402–408.CrossRefPubMed
11.
go back to reference Whitehead, S. J., & Ali, S. (2010). Health outcomes in economic evaluation: The QALY and utilities. British Medical Bulletin, 96, 5–21.CrossRefPubMed Whitehead, S. J., & Ali, S. (2010). Health outcomes in economic evaluation: The QALY and utilities. British Medical Bulletin, 96, 5–21.CrossRefPubMed
12.
go back to reference Revicki, D. A., & Wood, M. (1998). Patient-assigned health state utilities for depression-related outcomes: Differences by depression severity and antidepressant medications. Journal of Affective Disorders, 48(1), 25–36.CrossRefPubMed Revicki, D. A., & Wood, M. (1998). Patient-assigned health state utilities for depression-related outcomes: Differences by depression severity and antidepressant medications. Journal of Affective Disorders, 48(1), 25–36.CrossRefPubMed
13.
go back to reference Sobocki, P., Ekman, M., Agren, H., et al. (2007). Health-related quality of life measured with EQ-5D in patients treated for depression in primary care. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 10(2), 153–160.CrossRef Sobocki, P., Ekman, M., Agren, H., et al. (2007). Health-related quality of life measured with EQ-5D in patients treated for depression in primary care. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 10(2), 153–160.CrossRef
14.
go back to reference Group, E (1990). EuroQol–a new facility for the measurement of health-related quality of life. Health Policy (Amsterdam, Netherlands), 16(3), 199–208. Group, E (1990). EuroQol–a new facility for the measurement of health-related quality of life. Health Policy (Amsterdam, Netherlands), 16(3), 199–208.
15.
go back to reference Ware, J. E. Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.CrossRefPubMed Ware, J. E. Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.CrossRefPubMed
16.
go back to reference Chen, J., Wong, C. K., McGhee, S. M., et al. (2014). A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD). PLoS ONE, 9(11), e112389.CrossRefPubMedPubMedCentral Chen, J., Wong, C. K., McGhee, S. M., et al. (2014). A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD). PLoS ONE, 9(11), e112389.CrossRefPubMedPubMedCentral
17.
go back to reference Kontodimopoulos, N., Pappa, E., Papadopoulos, A. A., et al. (2009). Comparing SF-6D and EQ-5D utilities across groups differing in health status. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 18(1), 87–97.CrossRef Kontodimopoulos, N., Pappa, E., Papadopoulos, A. A., et al. (2009). Comparing SF-6D and EQ-5D utilities across groups differing in health status. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 18(1), 87–97.CrossRef
18.
go back to reference Mohiuddin, S., & Payne, K. (2014) Utility values for adults with unipolar depression systematic review and meta-analysis. Medical Decision Making, 34(5) 666–685. Mohiuddin, S., & Payne, K. (2014) Utility values for adults with unipolar depression systematic review and meta-analysis. Medical Decision Making, 34(5) 666–685.
19.
go back to reference Kind, P., Hardman, G., & Macran, S. (1999). UK population norms for EQ-5D. Vol. 172. Centre for Health Economics, University of York York. Kind, P., Hardman, G., & Macran, S. (1999). UK population norms for EQ-5D. Vol. 172. Centre for Health Economics, University of York York.
20.
go back to reference Brazier, J., Usherwood, T., Harper, R., et al. (1998). Deriving a preference-based single index from the UK SF-36 Health Survey. Journal of Clinical Epidemiology, 51(11), 1115–1128.CrossRefPubMed Brazier, J., Usherwood, T., Harper, R., et al. (1998). Deriving a preference-based single index from the UK SF-36 Health Survey. Journal of Clinical Epidemiology, 51(11), 1115–1128.CrossRefPubMed
21.
go back to reference Rush, A., First, M., & Blacker, D. (2008). American Psychiatric association: Task force for the handbook of psychiatric measures. Handbook of psychiatric measures Arington: American Psychiatric Pub. Rush, A., First, M., & Blacker, D. (2008). American Psychiatric association: Task force for the handbook of psychiatric measures. Handbook of psychiatric measures Arington: American Psychiatric Pub.
22.
go back to reference National Collaborating Centre for Mental Health. (2010). Depression in adults with a chronic physical health problem. British Psychological Society, UK. National Collaborating Centre for Mental Health. (2010). Depression in adults with a chronic physical health problem. British Psychological Society, UK.
23.
go back to reference Rasbash, J., C. Charlton, W.J. Browne, et al. (2009). MLwiN Version 2.1, in Centre for Multilevel Modelling: University of Bristol. Rasbash, J., C. Charlton, W.J. Browne, et al. (2009). MLwiN Version 2.1, in Centre for Multilevel Modelling: University of Bristol.
24.
go back to reference Maldonado, G., & Greenland, S. (1993). Simulation study of confounder-selection strategies. American Journal of Epidemiology, 138(11), 923–936.CrossRefPubMed Maldonado, G., & Greenland, S. (1993). Simulation study of confounder-selection strategies. American Journal of Epidemiology, 138(11), 923–936.CrossRefPubMed
25.
26.
go back to reference Lamers, L. M., Stalmeier, P. F., McDonnell, J., et al. (2005). Measuring the quality of life in economic evaluations: The Dutch EQ-5D tariff]. Nederlands Tijdschrift Voor Geneeskunde, 149(28), 1574–1578.PubMed Lamers, L. M., Stalmeier, P. F., McDonnell, J., et al. (2005). Measuring the quality of life in economic evaluations: The Dutch EQ-5D tariff]. Nederlands Tijdschrift Voor Geneeskunde, 149(28), 1574–1578.PubMed
27.
go back to reference Galante, J., Augustovski, F., Colantonio, L., et al. (2011). Estimation and comparison of EQ-5D health states’ utility weights for pneumococcal and human papillomavirus diseases in Argentina, Chile, and the United Kingdom. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 14(5 Suppl 1), S60–S64.CrossRef Galante, J., Augustovski, F., Colantonio, L., et al. (2011). Estimation and comparison of EQ-5D health states’ utility weights for pneumococcal and human papillomavirus diseases in Argentina, Chile, and the United Kingdom. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 14(5 Suppl 1), S60–S64.CrossRef
28.
go back to reference Badia, X., Roset, M., Herdman, M., et al. (2001). A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Medical Decision Making: An International Journal of the Society for Medical Decision Making, 21(1), 7–16.CrossRef Badia, X., Roset, M., Herdman, M., et al. (2001). A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Medical Decision Making: An International Journal of the Society for Medical Decision Making, 21(1), 7–16.CrossRef
29.
go back to reference Luo, N., Johnson, J. A., Shaw, J. W., et al. (2005). Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Medical Care, 43(11), 1078–1086.CrossRefPubMed Luo, N., Johnson, J. A., Shaw, J. W., et al. (2005). Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Medical Care, 43(11), 1078–1086.CrossRefPubMed
30.
go back to reference Prigent, A., Auraaen, A., Kamendje-Tchokobou, B., et al. (2014). Health-related quality of life and utility scores in people with mental disorders: A comparison with the non-mentally ill general population. International Journal of Environmental Research and Public Health, 11(3), 2804–2817.CrossRefPubMedPubMedCentral Prigent, A., Auraaen, A., Kamendje-Tchokobou, B., et al. (2014). Health-related quality of life and utility scores in people with mental disorders: A comparison with the non-mentally ill general population. International Journal of Environmental Research and Public Health, 11(3), 2804–2817.CrossRefPubMedPubMedCentral
31.
go back to reference IsHak, W. W., Greenberg, J. M., Balayan, K., et al. (2011). Quality of life: The ultimate outcome measure of interventions in major depressive disorder. Harvard Review of Psychiatry, 19(5), 229–239.CrossRefPubMed IsHak, W. W., Greenberg, J. M., Balayan, K., et al. (2011). Quality of life: The ultimate outcome measure of interventions in major depressive disorder. Harvard Review of Psychiatry, 19(5), 229–239.CrossRefPubMed
32.
go back to reference Zimmerman, M., Chelminski, I., McGlinchey, J. B., et al. (2006). Diagnosing major depressive disorder VI: Performance of an objective test as a diagnostic criterion. The Journal of Nervous and Mental Disease, 194(8), 565–569.CrossRefPubMed Zimmerman, M., Chelminski, I., McGlinchey, J. B., et al. (2006). Diagnosing major depressive disorder VI: Performance of an objective test as a diagnostic criterion. The Journal of Nervous and Mental Disease, 194(8), 565–569.CrossRefPubMed
33.
go back to reference Kolovos, S., Kleiboer, A., & Cuijpers, P. (2016). The effect of psychotherapy for depression on quality of life: A meta-analysis. British Journal of Psychiatry, 209, 1–9.CrossRef Kolovos, S., Kleiboer, A., & Cuijpers, P. (2016). The effect of psychotherapy for depression on quality of life: A meta-analysis. British Journal of Psychiatry, 209, 1–9.CrossRef
34.
go back to reference Brazier, J., Deverill, M., Green, C., et al. (1999). A review of the use of health status measures in economic evaluation. Health Technology Assessment Health Technol Assess (Rockv) Health Technology Assessment (Winchester, England), 3(9), 1–164. Brazier, J., Deverill, M., Green, C., et al. (1999). A review of the use of health status measures in economic evaluation. Health Technology Assessment Health Technol Assess (Rockv) Health Technology Assessment (Winchester, England), 3(9), 1–164.
35.
go back to reference Longworth, L., & Bryan, S. (2003). An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Economics, 12(12), 1061–1067.CrossRefPubMed Longworth, L., & Bryan, S. (2003). An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Economics, 12(12), 1061–1067.CrossRefPubMed
36.
go back to reference Brazier, J., Connell, J., Papaioannou, D., et al. (2014). A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technology Assessment Health Technol Assess (Rockv) Health Technology Assessment (Winchester, England), 18(34), 1–188 . Brazier, J., Connell, J., Papaioannou, D., et al. (2014). A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technology Assessment Health Technol Assess (Rockv) Health Technology Assessment (Winchester, England), 18(34), 1–188 .
37.
go back to reference Osoba, D., Rodrigues, G., Myles, J., et al. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 16(1), 139–144.CrossRef Osoba, D., Rodrigues, G., Myles, J., et al. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 16(1), 139–144.CrossRef
38.
go back to reference Jaeschke, R., Singer, J., & Guyatt, G. H. (1989). Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10(4), 407–415.CrossRefPubMed Jaeschke, R., Singer, J., & Guyatt, G. H. (1989). Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10(4), 407–415.CrossRefPubMed
39.
go back to reference Walters, S. J., & Brazier, J. E. (2005). Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Quality of life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 14(6), 1523–1532.CrossRef Walters, S. J., & Brazier, J. E. (2005). Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Quality of life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 14(6), 1523–1532.CrossRef
40.
go back to reference Barton, G. R., Sach, T. H., Avery, A. J., et al. (2008). A comparison of the performance of the EQ-5D and SF-6D for individuals aged > or = 45 years. Health Economics, 17(7), 815–832.CrossRefPubMed Barton, G. R., Sach, T. H., Avery, A. J., et al. (2008). A comparison of the performance of the EQ-5D and SF-6D for individuals aged > or = 45 years. Health Economics, 17(7), 815–832.CrossRefPubMed
41.
go back to reference Bryan, S., & Longworth, L. (2005). Measuring health-related utility: why the disparity between EQ-5D and SF-6D? The European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care, 6(3), 253–260.CrossRefPubMed Bryan, S., & Longworth, L. (2005). Measuring health-related utility: why the disparity between EQ-5D and SF-6D? The European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care, 6(3), 253–260.CrossRefPubMed
42.
go back to reference Rowen, D., Brazier, J., & Roberts, J. (2009). Mapping SF-36 onto the EQ-5D index: How reliable is the relationship? Health and Quality of Life Outcomes, 7, 27.CrossRefPubMedPubMedCentral Rowen, D., Brazier, J., & Roberts, J. (2009). Mapping SF-36 onto the EQ-5D index: How reliable is the relationship? Health and Quality of Life Outcomes, 7, 27.CrossRefPubMedPubMedCentral
43.
go back to reference McDonough, C. M., Grove, M. R., Tosteson, T. D., et al. (2005). Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among spine patient outcomes research trial (SPORT) participants. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 14(5), 1321–1332.CrossRef McDonough, C. M., Grove, M. R., Tosteson, T. D., et al. (2005). Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among spine patient outcomes research trial (SPORT) participants. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 14(5), 1321–1332.CrossRef
44.
go back to reference Gelman, A. (2006). Multilevel (Hierarchical) Modeling: What It Can and Cannot Do. Technometrics, 48(3), 432–435.CrossRef Gelman, A. (2006). Multilevel (Hierarchical) Modeling: What It Can and Cannot Do. Technometrics, 48(3), 432–435.CrossRef
45.
go back to reference Sonntag, M., König, H.-H., & Konnopka, A. (2013). The estimation of utility weights in cost-utility analysis for mental disorders: A systematic review. PharmacoEconomics, 31(12), 1131–1154.CrossRefPubMed Sonntag, M., König, H.-H., & Konnopka, A. (2013). The estimation of utility weights in cost-utility analysis for mental disorders: A systematic review. PharmacoEconomics, 31(12), 1131–1154.CrossRefPubMed
46.
go back to reference Kemmeren, L. L., van Schaik, D. J., Riper, H., et al. (2016). Effectiveness of blended depression treatment for adults in specialised mental healthcare: Study protocol for a randomised controlled trial. BMC Psychiatry, 16(1), 113.CrossRefPubMedPubMedCentral Kemmeren, L. L., van Schaik, D. J., Riper, H., et al. (2016). Effectiveness of blended depression treatment for adults in specialised mental healthcare: Study protocol for a randomised controlled trial. BMC Psychiatry, 16(1), 113.CrossRefPubMedPubMedCentral
47.
go back to reference Cameron, I. M., Cardy, A., Crawford, J. R., et al. (2011). Measuring depression severity in general practice: Discriminatory performance of the PHQ-9, HADS-D, and BDI-II. The British Journal of General Practice: The Journal of the Royal College of General Practitioners, 61(588), e419–e426.CrossRef Cameron, I. M., Cardy, A., Crawford, J. R., et al. (2011). Measuring depression severity in general practice: Discriminatory performance of the PHQ-9, HADS-D, and BDI-II. The British Journal of General Practice: The Journal of the Royal College of General Practitioners, 61(588), e419–e426.CrossRef
48.
go back to reference Herdman, M., Gudex, C., Lloyd, A., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.CrossRefPubMedPubMedCentral Herdman, M., Gudex, C., Lloyd, A., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.CrossRefPubMedPubMedCentral
49.
go back to reference Patten, S. B., Williams, J. V., Lavorato, D. H., et al. (2008). Major depression as a risk factor for chronic disease incidence: Longitudinal analyses in a general population cohort. General Hospital Psychiatry, 30(5), 407–413.CrossRefPubMed Patten, S. B., Williams, J. V., Lavorato, D. H., et al. (2008). Major depression as a risk factor for chronic disease incidence: Longitudinal analyses in a general population cohort. General Hospital Psychiatry, 30(5), 407–413.CrossRefPubMed
50.
go back to reference Moussavi, S., Chatterji, S., Verdes, E., et al. (2007). Depression, chronic diseases, and decrements in health: Results from the World Health Surveys. Lancet, 370(9590), 851–858.CrossRefPubMed Moussavi, S., Chatterji, S., Verdes, E., et al. (2007). Depression, chronic diseases, and decrements in health: Results from the World Health Surveys. Lancet, 370(9590), 851–858.CrossRefPubMed
51.
go back to reference Manea, L., Gilbody, S., & McMillan, D. (2012). Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): A meta-analysis. Canadian Medical Association Journal, 184(3), E191–E196.CrossRefPubMedPubMedCentral Manea, L., Gilbody, S., & McMillan, D. (2012). Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): A meta-analysis. Canadian Medical Association Journal, 184(3), E191–E196.CrossRefPubMedPubMedCentral
52.
go back to reference van Steenbergen-Weijenburg, K. M., de Vroege, L., Ploeger, R. R., et al. (2010). Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Services Research, 10, 235.CrossRefPubMedPubMedCentral van Steenbergen-Weijenburg, K. M., de Vroege, L., Ploeger, R. R., et al. (2010). Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Services Research, 10, 235.CrossRefPubMedPubMedCentral
53.
go back to reference Rush, A. J., Pincus, H. A., First, M. B., et al. (2000). Handbook of psychiatric measures. Washington, DC: American Psychiatric Association. Rush, A. J., Pincus, H. A., First, M. B., et al. (2000). Handbook of psychiatric measures. Washington, DC: American Psychiatric Association.
54.
go back to reference Carmody, T., Rush, A. J., Bernstein, I., et al. (2006). The Montgomery Äsberg and the Hamilton ratings of depression: A comparison of measures. European Neuropsychopharmacology, 16(8), 601–611.CrossRefPubMedPubMedCentral Carmody, T., Rush, A. J., Bernstein, I., et al. (2006). The Montgomery Äsberg and the Hamilton ratings of depression: A comparison of measures. European Neuropsychopharmacology, 16(8), 601–611.CrossRefPubMedPubMedCentral
55.
go back to reference Smaar, L. K., & Keefer, L. A. (2011). Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care & Research, 63(S11), S454–S466.CrossRef Smaar, L. K., & Keefer, L. A. (2011). Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care & Research, 63(S11), S454–S466.CrossRef
56.
go back to reference Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401.CrossRef Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401.CrossRef
57.
go back to reference Haringsma, R., Engels, G. I., Beekman, A. T., et al. (2004). The criterion validity of the center for epidemiological studies depression scale (CES-D) in a sample of self-referred elders with depressive symptomatology. International Journal of Geriatric Psychiatry, 19(6), 558–563.CrossRefPubMed Haringsma, R., Engels, G. I., Beekman, A. T., et al. (2004). The criterion validity of the center for epidemiological studies depression scale (CES-D) in a sample of self-referred elders with depressive symptomatology. International Journal of Geriatric Psychiatry, 19(6), 558–563.CrossRefPubMed
58.
go back to reference Trivedi, M. H., Rush, A. J., Ibrahim, H. M., et al. (2004). The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: A psychometric evaluation. Psychol Med, 34(1), 73–82.CrossRefPubMed Trivedi, M. H., Rush, A. J., Ibrahim, H. M., et al. (2004). The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: A psychometric evaluation. Psychol Med, 34(1), 73–82.CrossRefPubMed
59.
go back to reference Kessler, R. C., Berglund, P., Demler, O., et al. (2003). The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). Jama, 289(23), 3095–3105.CrossRefPubMed Kessler, R. C., Berglund, P., Demler, O., et al. (2003). The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). Jama, 289(23), 3095–3105.CrossRefPubMed
60.
go back to reference Fava, M., Rush, A. J., Trivedi, M. H., et al. (2003). Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatric Clinics of North America, 26(2), 457–494.CrossRefPubMed Fava, M., Rush, A. J., Trivedi, M. H., et al. (2003). Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatric Clinics of North America, 26(2), 457–494.CrossRefPubMed
62.
go back to reference Bosmans, J. E., van Schaik, D. J., Heymans, M. W., et al. (2007). Cost-effectiveness of interpersonal psychotherapy for elderly primary care patients with major depression. International Journal of Technology Assessment in Health Care, 23(4), 480–487.CrossRefPubMed Bosmans, J. E., van Schaik, D. J., Heymans, M. W., et al. (2007). Cost-effectiveness of interpersonal psychotherapy for elderly primary care patients with major depression. International Journal of Technology Assessment in Health Care, 23(4), 480–487.CrossRefPubMed
63.
go back to reference Bosmans, J. E., Dozeman, E., van Marwijk, H. W., et al. (2014). Cost-effectiveness of a stepped care programme to prevent depression and anxiety in residents in homes for the older people: A randomised controlled trial. International Journal of Geriatric Psychiatry, 29(2), 182–190.CrossRefPubMed Bosmans, J. E., Dozeman, E., van Marwijk, H. W., et al. (2014). Cost-effectiveness of a stepped care programme to prevent depression and anxiety in residents in homes for the older people: A randomised controlled trial. International Journal of Geriatric Psychiatry, 29(2), 182–190.CrossRefPubMed
64.
go back to reference Hermens, M. L., van Hout, H. P., Terluin, B., et al. (2007). Clinical effectiveness of usual care with or without antidepressant medication for primary care patients with minor or mild-major depression: A randomized equivalence trial. BMC Medicine, 5(1), 1–11.CrossRef Hermens, M. L., van Hout, H. P., Terluin, B., et al. (2007). Clinical effectiveness of usual care with or without antidepressant medication for primary care patients with minor or mild-major depression: A randomized equivalence trial. BMC Medicine, 5(1), 1–11.CrossRef
65.
go back to reference Huijbregts, K. M., de Jong, F. J., van Marwijk, H. W., et al. (2013). A target-driven collaborative care model for Major Depressive Disorder is effective in primary care in the Netherlands. A randomized clinical trial from the depression initiative. Journal of Affective Disorders, 146(3), 328–37.CrossRefPubMed Huijbregts, K. M., de Jong, F. J., van Marwijk, H. W., et al. (2013). A target-driven collaborative care model for Major Depressive Disorder is effective in primary care in the Netherlands. A randomized clinical trial from the depression initiative. Journal of Affective Disorders, 146(3), 328–37.CrossRefPubMed
66.
go back to reference van Marwijk, H. W., Ader, H., de Haan, M., et al. (2008). Primary care management of major depression in patients aged > or =55 years: Outcome of a randomised clinical trial. British Journal of General Practice, 58(555), 680–687CrossRefPubMedPubMedCentral van Marwijk, H. W., Ader, H., de Haan, M., et al. (2008). Primary care management of major depression in patients aged > or =55 years: Outcome of a randomised clinical trial. British Journal of General Practice, 58(555), 680–687CrossRefPubMedPubMedCentral
67.
go back to reference Schreuders, B., van Marwijk, H., Smit, J., et al. (2007). Primary care patients with mental health problems: Outcome of a randomised clinical trial. British Journal of General Practice, 57(544), 886–891.CrossRefPubMedPubMedCentral Schreuders, B., van Marwijk, H., Smit, J., et al. (2007). Primary care patients with mental health problems: Outcome of a randomised clinical trial. British Journal of General Practice, 57(544), 886–891.CrossRefPubMedPubMedCentral
68.
go back to reference Seekles, W., van Straten, A., Beekman, A., et al. (2011). Stepped care treatment for depression and anxiety in primary care. a randomized controlled trial. Trials, 12, 171.CrossRefPubMedPubMedCentral Seekles, W., van Straten, A., Beekman, A., et al. (2011). Stepped care treatment for depression and anxiety in primary care. a randomized controlled trial. Trials, 12, 171.CrossRefPubMedPubMedCentral
69.
go back to reference van Steenbergen-Weijenburg, K. M., van der Feltz-Cornelis, C. M., van Benthem, T. B., et al. (2015). Collaborative care voor de behandeling van comorbide depressieve stoornis bij chronisch lichamelijk zieke patiënten op een polikliniek van een algemeen ziekenhuis. Tijdschrift voor Psychiatrie, 57(4), 248–257.PubMed van Steenbergen-Weijenburg, K. M., van der Feltz-Cornelis, C. M., van Benthem, T. B., et al. (2015). Collaborative care voor de behandeling van comorbide depressieve stoornis bij chronisch lichamelijk zieke patiënten op een polikliniek van een algemeen ziekenhuis. Tijdschrift voor Psychiatrie, 57(4), 248–257.PubMed
70.
go back to reference van Straten, A., Cuijpers, P., & Smits, N. (2008). Effectiveness of a web-based self-help intervention for symptoms of depression, anxiety, and stress: Randomized controlled trial. Journal of Medical Internet Research, 10(1), e7.CrossRefPubMedPubMedCentral van Straten, A., Cuijpers, P., & Smits, N. (2008). Effectiveness of a web-based self-help intervention for symptoms of depression, anxiety, and stress: Randomized controlled trial. Journal of Medical Internet Research, 10(1), e7.CrossRefPubMedPubMedCentral
71.
go back to reference Warmerdam, L., Smit, F., van Straten, A., et al. (2010). Cost-utility and cost-effectiveness of Internet-based treatment for adults with depressive symptoms: Randomized trial. Journal of Medical Internet Research, 12(5), 40–50.CrossRef Warmerdam, L., Smit, F., van Straten, A., et al. (2010). Cost-utility and cost-effectiveness of Internet-based treatment for adults with depressive symptoms: Randomized trial. Journal of Medical Internet Research, 12(5), 40–50.CrossRef
Metadata
Title
Utility scores for different health states related to depression: individual participant data analysis
Authors
Spyros Kolovos
Judith E. Bosmans
Johanna M. van Dongen
Birre van Esveld
Dorcas Magai
Annemieke van Straten
Christina van der Feltz-Cornelis
Kirsten M. van Steenbergen-Weijenburg
Klaas M. Huijbregts
Harm van Marwijk
Heleen Riper
Maurits W. van Tulder
Publication date
01-07-2017
Publisher
Springer International Publishing
Published in
Quality of Life Research / Issue 7/2017
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-017-1536-2

Other articles of this Issue 7/2017

Quality of Life Research 7/2017 Go to the issue